Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 Mutations. Mason WP. J Clin Oncol 2022 Oct 26:JCO2201914. doi: 10.1200/JCO.22.01914.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mason WP. Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 Mutations. J Clin Oncol 2022 Oct 26:JCO2201914. doi: 10.1200/JCO.22.01914.
PMID: 36288506